Serenus Global
  • Home
  • Divisions
    • Psychedelics Division
    • Cannabis Division
  • Why Serenus
  • Shop
  • News
  • Contact Us
  • Investors
    • Investor Overview
    • Press Releases
    • Latest Presentation
    • Management Team
    • Corporate Charters
  • News
  • Shop
  • Contact Us
Select Page
BERKELEY OFFICIALLY DECRIMINALIZES POSSESSION OF PSILOCYBIN MUSHROOMS AND AYAHUASCA

BERKELEY OFFICIALLY DECRIMINALIZES POSSESSION OF PSILOCYBIN MUSHROOMS AND AYAHUASCA

Jul 12, 2023 | Psychedelics

BERKELEY OFFICIALLY DECRIMINALIZES POSSESSION OF PSILOCYBIN MUSHROOMS AND AYAHUASCA In an unanimous move, Berkeley has officially deprioritized arrests for possession and use of psilocybin and ayahuasca. Berkeley has long been an epicenter of psychedelic research and...
UC Berkeley Center for the Science of Psychedelics Unveils Results of the First-Ever Berkeley Psychedelics Survey

UC Berkeley Center for the Science of Psychedelics Unveils Results of the First-Ever Berkeley Psychedelics Survey

Jul 12, 2023 | Psychedelics

UC Berkeley Center for the Science of Psychedelics Unveils Results of the First-Ever Berkeley Psychedelics Survey More than six in ten (61%) American registered voters support legalizing regulated therapeutic access to psychedelics, including 35% who report “strong”...
Another California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill

Another California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill

Jul 11, 2023 | Psychedelics

Another California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill A second California Assembly committee has approved a Senate-passed bill to legalize the possession and facilitated use of certain psychedelics, bringing it one step closer to...
Psychedelic helpline shows promise in helping to manage safety issues and emotional challenges

Psychedelic helpline shows promise in helping to manage safety issues and emotional challenges

Jul 11, 2023 | Psychedelics

Psychedelic helpline shows promise in helping to manage safety issues and emotional challenges The presence of a psychedelic helpline appears to be beneficial in averting harmful outcomes and alleviating the burden on emergency services, according to new research...
PSILOCYBIN MAY BE MORE COST-EFFECTIVE THAN CURRENT TREATMENTS FOR DEPRESSION, MAJOR NEW STUDY FINDS

PSILOCYBIN MAY BE MORE COST-EFFECTIVE THAN CURRENT TREATMENTS FOR DEPRESSION, MAJOR NEW STUDY FINDS

Jul 6, 2023 | Psychedelics

PSILOCYBIN MAY BE MORE COST-EFFECTIVE THAN CURRENT TREATMENTS FOR DEPRESSION, MAJOR NEW STUDY FINDS A major new study has found that psilocybin-based treatment combined with therapy may provide more cost-effective solution to treating depression than methods such as...
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures

Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures

Jul 6, 2023 | Psychedelics

Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures The American Medical Association (AMA) published language concerning the recently-approved Current Procedural Terminology (CPT) III codes applying to psychedelic-assisted...
« Older Entries
Next Entries »
Email Alerts Shop Products

NEWSLETTER SIGNUP

NEWS

  • Company News
  • Industry News
  • Email Alerts

DIVISIONS

  • Psychedelics
  • Cannabis

INVESTORS

  • Press Releases
  • Latest Presentation
  • Board of Directors
  • Corporate Charters

COMPANY

  • Why Serenus
  • Management Team
  • Contact Us
  • FAQ’s
  • Facebook
  • Twitter
  • Instagram
© Copyright 2023 Serenus Global. All rights reserved.
Privacy PolicyTerms and Conditions